A number of firms have modified their ratings and price targets on shares of Procter & Gamble Company (The) (NYSE: PG) recently:

  • 10/24/2017 – Procter & Gamble Company (The) had its price target lowered by analysts at Morgan Stanley from $91.00 to $90.00. They now have an “equal weight” rating on the stock.
  • 10/23/2017 – Procter & Gamble Company (The) was upgraded by analysts at Vetr from a “hold” rating to a “buy” rating. They now have a $93.02 price target on the stock.
  • 10/23/2017 – Procter & Gamble Company (The) had its “buy” rating reaffirmed by analysts at Royal Bank Of Canada.
  • 10/20/2017 – Procter & Gamble Company (The) was given a new $87.00 price target on by analysts at Stifel Nicolaus. They now have a “hold” rating on the stock.
  • 10/18/2017 – Procter & Gamble Company (The) was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “P&G is known for its strong brand recognition, diversified portfolio, impressive product development capabilities and marketing prowess as well as strong cash flow productivity. The company is investing in its brands and products as well as redesigning the supply chain to improve productivity and organic growth. However, slowing market growth, weak volumes and  major foreign exchange headwind have been hurting sales. P&G shares have also underperformed the industry year to date. Soft consumer-spending environment in developed markets and uncertainties in emerging countries also add to the worries. That said, P&G is speeding up innovations and investments to counter the softening industry growth. Its productivity improvements and cost-saving efforts are also consistently helping to boost profit level.”
  • 10/10/2017 – Procter & Gamble Company (The) had its “buy” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $104.00 price target on the stock. They wrote, “We continue to see a favorable set-up for P&G’s shares following preliminary shareholder vote results today that denied Nelson Peltz a Board seat. While Trian plans to challenge the close result, the razor-thin margin suggests: (i) a decisive openness to Mr. Peltz’s ideas; and (ii) appetite for greater accountability from P&G’s Board. We see it likely that Mr. Peltz sticks around which should continue to raise the execution bar” at P&G.””
  • 10/4/2017 – Procter & Gamble Company (The) had its “sell” rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The).
  • 9/20/2017 – Procter & Gamble Company (The) had its “buy” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $104.00 price target on the stock, up previously from $103.00.
  • 9/19/2017 – Procter & Gamble Company (The) had its price target raised by analysts at Bank of America Corporation from $98.00 to $100.00. They now have a “buy” rating on the stock.
  • 9/15/2017 – Procter & Gamble Company (The) was upgraded by analysts at Vetr from a “sell” rating to a “hold” rating. They now have a $93.02 price target on the stock.
  • 9/14/2017 – Procter & Gamble Company (The) is now covered by analysts at Macquarie. They set an “outperform” rating and a $102.00 price target on the stock.
  • 9/7/2017 – Procter & Gamble Company (The) had its “buy” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $103.00 price target on the stock.
  • 9/6/2017 – Procter & Gamble Company (The) had its “outperform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $80.00 price target on the stock.

Procter & Gamble Company (PG) opened at 86.34 on Wednesday. The stock has a 50 day moving average of $91.29 and a 200-day moving average of $89.71. The company has a market cap of $220.17 billion, a PE ratio of 15.44 and a beta of 0.67. Procter & Gamble Company has a 12-month low of $81.18 and a 12-month high of $94.67.

Procter & Gamble Company (The) (NYSE:PG) last posted its earnings results on Friday, October 20th. The company reported $1.09 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.07 by $0.02. The business had revenue of $16.65 billion during the quarter, compared to analyst estimates of $16.69 billion. Procter & Gamble Company (The) had a return on equity of 20.35% and a net margin of 23.72%. The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.03 EPS. On average, equities research analysts anticipate that Procter & Gamble Company will post $4.17 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Friday, October 20th will be given a dividend of $0.6896 per share. The ex-dividend date of this dividend is Thursday, October 19th. This represents a $2.76 dividend on an annualized basis and a dividend yield of 3.19%. Procter & Gamble Company (The)’s dividend payout ratio (DPR) is presently 48.51%.

In other news, SVP Valarie L. Sheppard sold 20,175 shares of Procter & Gamble Company (The) stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $92.65, for a total transaction of $1,869,213.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David S. Taylor sold 6,382 shares of Procter & Gamble Company (The) stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $92.04, for a total value of $587,399.28. Following the sale, the chief executive officer now owns 134,884 shares of the company’s stock, valued at approximately $12,414,723.36. The disclosure for this sale can be found here. In the last quarter, insiders have sold 38,136 shares of company stock valued at $3,525,029. Corporate insiders own 0.35% of the company’s stock.

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.

Receive News & Ratings for Procter & Gamble Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.